| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |